US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 25.760
  • -1.160-4.31%
Close Dec 18 16:00 ET
  • 25.110
  • -0.650-2.52%
Pre 05:45 ET
868.04MMarket Cap-10.71P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
-8.61M
-16.88M
-43.63M
-15.89M
Net income from continuing operations
-42.80%-20.56M
-1.42%-21.87M
-43.09%-17.42M
-87.86%-69.33M
-102.96%-21.19M
-22.37%-14.4M
---21.57M
---12.17M
---36.91M
---10.44M
Change In working capital
366.53%3.35M
-84.16%2.02M
62.34%-1.84M
276.19%12.6M
207.25%5.96M
-172.76%-1.26M
--12.77M
---4.88M
---7.15M
---5.56M
-Change in prepaid assets
-86.35%298K
-95.83%246K
79.30%-508K
171.23%9.67M
176.22%4.04M
167.29%2.18M
--5.9M
---2.45M
---13.58M
---5.3M
-Change in payables and accrued expense
188.64%3.06M
-73.84%1.8M
44.71%-1.34M
-54.23%2.94M
850.97%1.93M
-169.45%-3.45M
--6.87M
---2.42M
--6.41M
---257K
-Change in other current assets
--0
-157.14%-18K
66.67%-1K
-318.75%-35K
-3,600.00%-35K
150.00%10K
---7K
---3K
--16K
--1K
-Change in other current liabilities
---4K
---4K
--10K
--25K
--25K
--0
--0
--0
--0
----
Cash from discontinued investing activities
Operating cash flow
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
---43.63M
---15.89M
Investing cash flow
Cash flow from continuing investing activities
0
0
25M
0
0
0
Net investment purchase and sale
--0
----
----
--0
--25M
--0
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
----
----
--0
--25M
--0
----
----
--0
--0
Financing cash flow
Cash flow from continuing financing activities
151.40%531K
1,915.00%363K
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
-1.03M
-20K
44.97M
169.72M
109.72M
Net common stock issuance
--0
--319K
--185.63M
--0
--0
--0
--0
--0
--2K
--0
Net preferred stock issuance
--0
--0
--0
-73.53%44.92M
--0
--0
---24K
--44.94M
--169.71M
--109.71M
Proceeds from stock option exercised by employees
1,261.54%531K
1,000.00%44K
-96.15%1K
2,260.00%354K
1,800.00%285K
--39K
--4K
--26K
--15K
--15K
Net other financing activities
----
----
----
---2.41M
---1.34M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
151.40%531K
1,915.00%363K
312.80%185.63M
-74.75%42.86M
-100.96%-1.06M
---1.03M
---20K
--44.97M
--169.72M
--109.72M
Net cash flow
Beginning cash position
89.23%298.67M
65.78%317.39M
-7.95%150.39M
338.23%163.37M
103.28%141.36M
98.62%157.83M
--191.46M
--163.37M
--37.28M
--69.54M
Current changes in cash
4.01%-15.81M
44.32%-18.72M
494.57%167M
-110.30%-12.98M
-90.38%9.03M
-65.98%-16.48M
---33.63M
--28.09M
--126.09M
--93.83M
End cash Position
100.10%282.86M
89.23%298.67M
65.78%317.39M
-7.95%150.39M
-7.95%150.39M
103.28%141.36M
--157.83M
--191.46M
--163.37M
--163.37M
Free cash flow
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
-27.99%-55.84M
6.13%-14.91M
-55.57%-15.44M
---8.61M
---16.88M
---43.63M
---15.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M-8.61M-16.88M-43.63M-15.89M
Net income from continuing operations -42.80%-20.56M-1.42%-21.87M-43.09%-17.42M-87.86%-69.33M-102.96%-21.19M-22.37%-14.4M---21.57M---12.17M---36.91M---10.44M
Change In working capital 366.53%3.35M-84.16%2.02M62.34%-1.84M276.19%12.6M207.25%5.96M-172.76%-1.26M--12.77M---4.88M---7.15M---5.56M
-Change in prepaid assets -86.35%298K-95.83%246K79.30%-508K171.23%9.67M176.22%4.04M167.29%2.18M--5.9M---2.45M---13.58M---5.3M
-Change in payables and accrued expense 188.64%3.06M-73.84%1.8M44.71%-1.34M-54.23%2.94M850.97%1.93M-169.45%-3.45M--6.87M---2.42M--6.41M---257K
-Change in other current assets --0-157.14%-18K66.67%-1K-318.75%-35K-3,600.00%-35K150.00%10K---7K---3K--16K--1K
-Change in other current liabilities ---4K---4K--10K--25K--25K--0--0--0--0----
Cash from discontinued investing activities
Operating cash flow -5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M---43.63M---15.89M
Investing cash flow
Cash flow from continuing investing activities 0025M000
Net investment purchase and sale --0----------0--25M--0----------0--0
Cash from discontinued investing activities
Investing cash flow --0----------0--25M--0----------0--0
Financing cash flow
Cash flow from continuing financing activities 151.40%531K1,915.00%363K312.80%185.63M-74.75%42.86M-100.96%-1.06M-1.03M-20K44.97M169.72M109.72M
Net common stock issuance --0--319K--185.63M--0--0--0--0--0--2K--0
Net preferred stock issuance --0--0--0-73.53%44.92M--0--0---24K--44.94M--169.71M--109.71M
Proceeds from stock option exercised by employees 1,261.54%531K1,000.00%44K-96.15%1K2,260.00%354K1,800.00%285K--39K--4K--26K--15K--15K
Net other financing activities ---------------2.41M---1.34M--------------------
Cash from discontinued financing activities
Financing cash flow 151.40%531K1,915.00%363K312.80%185.63M-74.75%42.86M-100.96%-1.06M---1.03M---20K--44.97M--169.72M--109.72M
Net cash flow
Beginning cash position 89.23%298.67M65.78%317.39M-7.95%150.39M338.23%163.37M103.28%141.36M98.62%157.83M--191.46M--163.37M--37.28M--69.54M
Current changes in cash 4.01%-15.81M44.32%-18.72M494.57%167M-110.30%-12.98M-90.38%9.03M-65.98%-16.48M---33.63M--28.09M--126.09M--93.83M
End cash Position 100.10%282.86M89.23%298.67M65.78%317.39M-7.95%150.39M-7.95%150.39M103.28%141.36M--157.83M--191.46M--163.37M--163.37M
Free cash flow -5.85%-16.35M-121.79%-19.09M-10.35%-18.63M-27.99%-55.84M6.13%-14.91M-55.57%-15.44M---8.61M---16.88M---43.63M---15.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data